Trials / Conditions / H3 K27M
H3 K27M
4 registered clinical trials studyying H3 K27M — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age NCT05956821 | University of Miami | Phase 1 / Phase 2 |
| Recruiting | ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) NCT05580562 | Jazz Pharmaceuticals | Phase 3 |
| Approved For Marketing | Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas NCT04617002 | Jazz Pharmaceuticals | — |
| No Longer Available | Single Patient Compassionate Use / Expanded Access L-S-Gboxin (Lyophilized Form of S-Gboxin) for the Treatment NCT06439849 | Petrov, Andrey | — |